van Meijgaarden KE[au] - Search Results

Year	Number of Results
1992	1
1993	2
1994	2
1995	1
1997	4
1998	5
1999	2
2000	6
2001	2
2002	3
2003	1
2004	2
2005	2
2006	1
2007	4
2009	2
2010	3
2011	4
2012	4
2013	3
2014	6
2015	6
2016	3
2017	4
2018	4
2019	2
2020	2
2022	2

1

Innovative Strategies to Identify M. tuberculosis Antigens and Epitopes Using Genome-Wide Analyses.

Geluk A, van Meijgaarden KE, Joosten SA, Commandeur S, Ottenhoff TH. Geluk A, et al. Among authors: van meijgaarden ke. Front Immunol. 2014 Jun 25;5:256. doi: 10.3389/fimmu.2014.00256. eCollection 2014. Front Immunol. 2014. PMID: 25009541 Free PMC article. Review.

2

Mycobacterial growth inhibition is associated with trained innate immunity.

Joosten SA, van Meijgaarden KE, Arend SM, Prins C, Oftung F, Korsvold GE, Kik SV, Arts RJ, van Crevel R, Netea MG, Ottenhoff TH. Joosten SA, et al. Among authors: van meijgaarden ke. J Clin Invest. 2018 May 1;128(5):1837-1851. doi: 10.1172/JCI97508. Epub 2018 Apr 3. J Clin Invest. 2018. PMID: 29461976 Free PMC article.

3

T-cell regulation in lepromatous leprosy.

Bobosha K, Wilson L, van Meijgaarden KE, Bekele Y, Zewdie M, van der Ploeg-van Schip JJ, Abebe M, Hussein J, Khadge S, Neupane KD, Hagge DA, Jordanova ES, Aseffa A, Ottenhoff TH, Geluk A. Bobosha K, et al. Among authors: van meijgaarden ke. PLoS Negl Trop Dis. 2014 Apr 10;8(4):e2773. doi: 10.1371/journal.pntd.0002773. eCollection 2014 Apr. PLoS Negl Trop Dis. 2014. PMID: 24722473 Free PMC article.

4

Biomarkers to identify Mycobacterium tuberculosis-infection among borderline QuantiFERON results.

Uzorka JW, Bakker JA, van Meijgaarden KE, Leyten EMS, Delfos NM, Hetem DJ, Kerremans J, Zwarts M, Cozijn S, Ottenhoff THM, Joosten SA, Arend SM. Uzorka JW, et al. Among authors: van meijgaarden ke. Eur Respir J. 2022 Jan 20:2102665. doi: 10.1183/13993003.02665-2021. Online ahead of print. Eur Respir J. 2022. PMID: 35058249

5

Disparate Tuberculosis Disease Development in Macaque Species Is Associated With Innate Immunity.

Dijkman K, Vervenne RAW, Sombroek CC, Boot C, Hofman SO, van Meijgaarden KE, Ottenhoff THM, Kocken CHM, Haanstra KG, Vierboom MPM, Verreck FAW. Dijkman K, et al. Among authors: van meijgaarden ke. Front Immunol. 2019 Nov 1;10:2479. doi: 10.3389/fimmu.2019.02479. eCollection 2019. Front Immunol. 2019. PMID: 31736945 Free PMC article.

6

Detailed characterization of human Mycobacterium tuberculosis specific HLA-E restricted CD8⁺ T cells.

Prezzemolo T, van Meijgaarden KE, Franken KLMC, Caccamo N, Dieli F, Ottenhoff THM, Joosten SA. Prezzemolo T, et al. Among authors: van meijgaarden ke. Eur J Immunol. 2018 Feb;48(2):293-305. doi: 10.1002/eji.201747184. Epub 2017 Dec 15. Eur J Immunol. 2018. PMID: 29124751 Free PMC article.

7

Cell-Mediated Immune Responses to in vivo-Expressed and Stage-Specific Mycobacterium tuberculosis Antigens in Latent and Active Tuberculosis Across Different Age Groups.

Coppola M, Villar-Hernández R, van Meijgaarden KE, Latorre I, Muriel Moreno B, Garcia-Garcia E, Franken KLMC, Prat C, Stojanovic Z, De Souza Galvão ML, Millet JP, Sabriá J, Sánchez-Montalva A, Noguera-Julian A, Geluk A, Domínguez J, Ottenhoff THM. Coppola M, et al. Among authors: van meijgaarden ke. Front Immunol. 2020 Feb 11;11:103. doi: 10.3389/fimmu.2020.00103. eCollection 2020. Front Immunol. 2020. PMID: 32117257 Free PMC article.

8

Peptide Binding to HLA-E Molecules in Humans, Nonhuman Primates, and Mice Reveals Unique Binding Peptides but Remarkably Conserved Anchor Residues.

Ruibal P, Franken KLMC, van Meijgaarden KE, van Loon JJF, van der Steen D, Heemskerk MHM, Ottenhoff THM, Joosten SA. Ruibal P, et al. Among authors: van meijgaarden ke. J Immunol. 2020 Nov 15;205(10):2861-2872. doi: 10.4049/jimmunol.2000810. Epub 2020 Oct 5. J Immunol. 2020. PMID: 33020145 Free PMC article.

9

Immunological characterization of latent tuberculosis infection in a low endemic country.

de Paus RA, van Meijgaarden KE, Prins C, Kamphorst MH, Arend SM, Ottenhoff THM, Joosten SA. de Paus RA, et al. Among authors: van meijgaarden ke. Tuberculosis (Edinb). 2017 Sep;106:62-72. doi: 10.1016/j.tube.2017.07.001. Epub 2017 Jul 4. Tuberculosis (Edinb). 2017. PMID: 28802407

10

A novel view on the pathogenesis of complications after intravesical BCG for bladder cancer.

Bilsen MP, van Meijgaarden KE, de Jong HK, Joosten SA, Prins C, Kroft LJM, Jonker JT, Crobach S, Pelger RC, Ottenhoff THM, Arend SM. Bilsen MP, et al. Among authors: van meijgaarden ke. Int J Infect Dis. 2018 Jul;72:63-68. doi: 10.1016/j.ijid.2018.05.006. Epub 2018 May 17. Int J Infect Dis. 2018. PMID: 29778583 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results